...LAV), Hillhouse Capital Group and CDH Investments. The round brings the total raised by Shanghai-based Elpiscience Biopharmaceuticals Co. Ltd....
...research; Arch was executive director of the Novartis Institutes for Biomedical Research (NIBR) in China. Elpiscience...
...in China. Elpiscience gained China rights to ES101 (INBRX-105) from Inhibrx Inc. The rest of Elpiscience’s...

...Capital Management. Existing investor Lilly Asia Ventures and CDH Investments also participated in the round. Elpiscience...
...a series A last year from Lilly Asia Ventures. Elpiscience Biopharma Ltd., Shanghai, China Elizabeth S. Eaton Elpiscience...

...Capital Management. Existing investor Lilly Asia Ventures and CDH Investments also participated in the round. Elpiscience...
...raised $20 million in a series A last year from Lilly Asia Ventures. Elizabeth S. Eaton ES101, INBRX-105 Elpiscience Biopharmaceuticals Co. Ltd. Lilly...

...sector, causing investors to look beyond their own borders. Darren Ji, founder and CEO of Elpiscience Biopharmaceuticals Co. Ltd....
...people, and two are investors -- one of whom is in life sciences.” Darren Ji, Elpiscience Biopharmaceuticals Co. Ltd....
...plc (LSE:ARIX), London, U.K. Cellectis S.A. (Euronext:ALCLS; NASDAQ:CLLS), Paris, France Crescendo Biologics Ltd., Cambridge, U.K. Elpiscience Biopharmaceuticals Co. Ltd....

...2016 IDO AHR Preclin Kynurenine Preclin Arrys Therapeutics Inc. PGE2 PTGER4 Ph I $21 2017 Elpiscience Biopharmaceuticals Co. Ltd....

...Patent application filed Company; lead investigator Elpiscience Biopharmaceuticals Co. Ltd., Inhibrx LLC Mustering a cluster Ji told BioCentury Elpiscience...
...recognize things in China are probably better handled by locals.” Darren Ji, Elpiscience Ji believes Elpiscience’s...
...Elpiscience “to tap into treatment-naïve patients. In the U.S., these patients are hard to find.” Elpiscience...